GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, engages in the provision of patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases in the United States. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in New York, New York.
Frequently asked questions
What sector does AngioSoma Inc (GSTC) operate in?
AngioSoma Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is AngioSoma Inc (GSTC) current stock price?
As of the latest data, AngioSoma Inc stock price is $0.00, with a previous close of $0.00.
What is AngioSoma Inc (GSTC) current market capitalization?
AngioSoma Inc market cap is approximately 124.11 thousand.
Does AngioSoma Inc (GSTC) pay dividends?
No. AngioSoma Inc does not pay a dividend.
What is AngioSoma Inc (GSTC) beta (volatility) score?
AngioSoma Inc has a beta of 1.115, meaning its volatility is roughly in line with the market.